Theriva Biologics (TOVX) Other financing activities (2010 - 2021)
Theriva Biologics (TOVX) posted quarterly Other financing activities of $42000.0 for Q2 2021, down 99.48% quarter-over-quarter from $8.0 million in Q1 2021.
Theriva Biologics (TOVX) Other financing activities (2010 - 2021) Analysis & Trends
Theriva Biologics (TOVX) has reported Other financing activities for 5 consecutive years, with $42000.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Other financing activities changed N/A year-over-year to $42000.0; the TTM figure through Mar 2022 stood at $42000.0 (down 99.48% YoY), while the FY2025 annual figure was $4000.0, changed N/A from the prior year.
- Other financing activities declined to $42000.0 in Q2 2021 per TOVX's latest filing, from $8.0 million in the prior quarter.
- Across five years, Other financing activities topped out at $8.0 million in Q1 2021 and bottomed at $42000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 42,000.00 |
| Jun 30, 2021 | 42,000.00 |
| Mar 31, 2021 | 8.00 Mn |
| Mar 31, 2021 | 8.00 Mn |
| Dec 31, 2013 | 1,000.00 |
| Dec 31, 2013 | 1,000.00 |
| Dec 31, 2012 | -1.96 Mn |
| Dec 31, 2012 | -1.96 Mn |
| Sep 30, 2012 | 94,000.00 |
| Sep 30, 2012 | 94,000.00 |
| Jun 30, 2012 | 390,000.00 |
| Jun 30, 2012 | 390,000.00 |
| Mar 31, 2012 | 1.47 Mn |
| Mar 31, 2012 | 1.47 Mn |
| Dec 31, 2011 | 15,000.00 |
| Dec 31, 2011 | 15,000.00 |
| Dec 31, 2010 | 7,122.00 |
| Dec 31, 2010 | 7,122.00 |
| Sep 30, 2010 | 32,721.00 |
| Sep 30, 2010 | 32,721.00 |